Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

90 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Proteomic analysis of normal and malignant prostate tissue to identify novel proteins lost in cancer.
Meehan KL, Holland JW, Dawkins HJ. Meehan KL, et al. Among authors: dawkins hj. Prostate. 2002 Jan 1;50(1):54-63. doi: 10.1002/pros.10032. Prostate. 2002. PMID: 11757036
Purification of the keratan sulfate proteoglycan expressed in prostatic secretory cells and its identification as lumican.
Holland JW, Meehan KL, Redmond SL, Dawkins HJ. Holland JW, et al. Among authors: dawkins hj. Prostate. 2004 May 15;59(3):252-9. doi: 10.1002/pros.20002. Prostate. 2004. PMID: 15042600
Murine progesterone receptor expression in proliferating mammary epithelial cells during normal pubertal development and adult estrous cycle. Association with eralpha and erbeta status.
Zeps N, Bentel JM, Papadimitriou JM, Dawkins HJ. Zeps N, et al. Among authors: dawkins hj. J Histochem Cytochem. 1999 Oct;47(10):1323-30. doi: 10.1177/002215549904701012. J Histochem Cytochem. 1999. PMID: 10490461
Androgen receptor expression of proliferating basal and luminal cells in adult murine ventral prostate.
Mirosevich J, Bentel JM, Zeps N, Redmond SL, D'Antuono MF, Dawkins HJ. Mirosevich J, et al. Among authors: dawkins hj. J Endocrinol. 1999 Sep;162(3):341-50. doi: 10.1677/joe.0.1620341. J Endocrinol. 1999. PMID: 10467225
Distinction between intraductal carcinoma of the prostate (IDC-P), high-grade dysplasia (PIN), and invasive prostatic adenocarcinoma, using molecular markers of cancer progression.
Dawkins HJ, Sellner LN, Turbett GR, Thompson CA, Redmond SL, McNeal JE, Cohen RJ. Dawkins HJ, et al. Prostate. 2000 Sep 1;44(4):265-70. doi: 10.1002/1097-0045(20000901)44:4<265::aid-pros1>;2-i. Prostate. 2000. PMID: 10951489
Prognostic significance of p53 over-expression in thin melanomas.
Sparrow LE, English DR, Heenan PJ, Dawkins HJ, Taran J. Sparrow LE, et al. Among authors: dawkins hj. Melanoma Res. 1995 Dec;5(6):387-92. doi: 10.1097/00008390-199512000-00001. Melanoma Res. 1995. PMID: 8589612
What's new in breast cancer? Molecular perspectives of cancer development and the role of the oncogene c-erbB-2 in prognosis and disease.
Dawkins HJ, Robbins PD, Smith KL, Sarna M, Harvey JM, Sterrett GF, Papadimitriou JM. Dawkins HJ, et al. Pathol Res Pract. 1993 Dec;189(10):1233-52. doi: 10.1016/S0344-0338(11)80853-8. Pathol Res Pract. 1993. PMID: 7910395 Review.
c-erbB-2 amplification in breast cancer: detection in formalin-fixed, paraffin-embedded tissue by in situ hybridization.
Smith KL, Robbins PD, Dawkins HJ, Papadimitriou JM, Redmond SL, Carrello S, Harvey JM, Sterrett GF. Smith KL, et al. Among authors: dawkins hj. Hum Pathol. 1994 Apr;25(4):413-8. doi: 10.1016/0046-8177(94)90152-x. Hum Pathol. 1994. PMID: 7909307
p53 gene mutation and expression in naevi and melanomas.
Sparrow LE, Soong R, Dawkins HJ, Iacopetta BJ, Heenan PJ. Sparrow LE, et al. Among authors: dawkins hj. Melanoma Res. 1995 Apr;5(2):93-100. doi: 10.1097/00008390-199504000-00004. Melanoma Res. 1995. PMID: 7620345
Evaluation of the expression levels of nm23-H1 mRNA in primary breast cancer, benign breast disease, axillary lymph nodes and normal breast tissue.
Goodall RJ, Dawkins HJ, Robbins PD, Hähnel E, Sarna M, Hähnel R, Papadimitriou JM, Harvey JM, Sterrett GF. Goodall RJ, et al. Among authors: dawkins hj. Pathology. 1994 Oct;26(4):423-8. doi: 10.1080/00313029400169122. Pathology. 1994. PMID: 7892043
90 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page